市場調査レポート

商品コード

1121160

世界の男性の性腺機能低下症市場：考察と予測 (2028年まで)

Global Male Hypogonadism Market Insights, Forecast to 2028

出版日: 2022年09月01日 | 発行: QYResearch

| ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,152,186円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,536,248円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、男性の性腺機能低下症 (Male Hypogonadism) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

調査範囲
市場分析：タイプ別
- 世界の男性の性腺機能低下症の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Testosterone Replacement Therapy
- Gonadotropin-Releasing Hormones Therapy
市場：アプリケーション別
- 世界の男性の性腺機能低下症の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Kallmann Syndrome
- Klinefelters Syndrome
- Pituitary Disorders
- Others
調査目的
対象期間

第2章世界の市場成長トレンド

世界の男性の性腺機能低下症の市場展望 (2017-2028)
男性の性腺機能低下症の市場成長トレンド：地域別
- 男性の性腺機能低下症市場規模：地域別: 2017 VS 2021 VS 2028
- 男性の性腺機能低下症の市場規模実績：地域別 (2017-2022)
- 男性の性腺機能低下症の市場規模予測：地域別 (2023-2028)
男性の性腺機能低下症市場動向
- 男性の性腺機能低下症業界動向
- 男性の性腺機能低下症市場の促進要因
- 男性の性腺機能低下症市場の課題
- 男性の性腺機能低下症市場の抑制要因

第3章競合情勢：主要企業別

世界の男性の性腺機能低下症の上位企業：収益別
- 世界の男性の性腺機能低下症の上位企業：収益別 (2017-2022)
- 世界の男性の性腺機能低下症の収益シェア：企業別 (2017-2022)
世界の男性の性腺機能低下症の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
企業ランキング：男性の性腺機能低下症の収益
世界の男性の性腺機能低下症市場集中度
- 世界の男性の性腺機能低下症市場集中度 (CR5 and HHI)
- 世界の上位10・上位5企業：男性の性腺機能低下症の収益 2021
男性の性腺機能低下症の主要企業の本社および事業エリア
主要企業男性の性腺機能低下症の製品ソリューションおよびサービス
市場参入時期：男性の性腺機能低下症市場
M&A, 拡張計画

第4章男性の性腺機能低下症内訳データ：タイプ別

世界の男性の性腺機能低下症の市場規模実績：タイプ別 (2017-2022)
世界の男性の性腺機能低下症の市場規模予測：タイプ別 (2023-2028)

第5章男性の性腺機能低下症内訳データ：アプリケーション別

世界の男性の性腺機能低下症の市場規模実績：アプリケーション別 (2017-2022)
世界の男性の性腺機能低下症の市場規模予測：アプリケーション別 (2023-2028)

第6章北米

北米の男性の性腺機能低下症市場規模 (2017-2028)
北米の男性の性腺機能低下症市場規模：タイプ別
- 北米の男性の性腺機能低下症市場規模：タイプ別 (2017-2022)
- 北米の男性の性腺機能低下症市場規模：タイプ別 (2023-2028)
- 北米の男性の性腺機能低下症の市場シェア：タイプ別 (2017-2028)
北米の男性の性腺機能低下症市場規模：アプリケーション別
- 北米の男性の性腺機能低下症市場規模：アプリケーション別 (2017-2022)
- 北米の男性の性腺機能低下症市場規模：アプリケーション別 (2023-2028)
- 北米の男性の性腺機能低下症の市場シェア：アプリケーション別 (2017-2028)
北米の男性の性腺機能低下症市場規模：国別
- 北米の男性の性腺機能低下症市場規模：国別 (2017-2022)
- 北米の男性の性腺機能低下症市場規模：国別 (2023-2028)
- 米国
- カナダ

第7章欧州

欧州の男性の性腺機能低下症市場規模 (2017-2028)
欧州の男性の性腺機能低下症市場規模：タイプ別
- 欧州の男性の性腺機能低下症市場規模：タイプ別 (2017-2022)
- 欧州の男性の性腺機能低下症市場規模：タイプ別 (2023-2028)
- 欧州の男性の性腺機能低下症の市場シェア：タイプ別 (2017-2028)
欧州の男性の性腺機能低下症市場規模：アプリケーション別
- 欧州の男性の性腺機能低下症市場規模：アプリケーション別 (2017-2022)
- 欧州の男性の性腺機能低下症市場規模：アプリケーション別 (2023-2028)
- 欧州の男性の性腺機能低下症の市場シェア：アプリケーション別 (2017-2028)
欧州の男性の性腺機能低下症市場規模：国別
- 欧州の男性の性腺機能低下症市場規模：国別 (2017-2022)
- 欧州の男性の性腺機能低下症市場規模：国別 (2023-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア
- 北欧

第8章アジア太平洋地域

アジア太平洋地域男性の性腺機能低下症市場規模 (2017-2028)
アジア太平洋地域男性の性腺機能低下症市場規模：タイプ別
- アジア太平洋地域男性の性腺機能低下症市場規模：タイプ別 (2017-2022)
- アジア太平洋地域男性の性腺機能低下症市場規模：タイプ別 (2023-2028)
- アジア太平洋地域男性の性腺機能低下症の市場シェア：タイプ別 (2017-2028)
アジア太平洋地域男性の性腺機能低下症市場規模：アプリケーション別
- アジア太平洋地域男性の性腺機能低下症市場規模：アプリケーション別 (2017-2022)
- アジア太平洋地域男性の性腺機能低下症市場規模：アプリケーション別 (2023-2028)
- アジア太平洋地域男性の性腺機能低下症の市場シェア：アプリケーション別 (2017-2028)
アジア太平洋地域男性の性腺機能低下症市場規模：地域別
- アジア太平洋地域男性の性腺機能低下症市場規模：地域別 (2017-2022)
- アジア太平洋地域男性の性腺機能低下症市場規模：地域別 (2023-2028)
- 中国
- 日本
- 韓国
- 東南アジア
- インド
- オーストラリア

第9章ラテンアメリカ

ラテンアメリカの男性の性腺機能低下症市場規模 (2017-2028)
ラテンアメリカの男性の性腺機能低下症市場規模：タイプ別
- ラテンアメリカの男性の性腺機能低下症市場規模：タイプ別 (2017-2022)
- ラテンアメリカの男性の性腺機能低下症市場規模：タイプ別 (2023-2028)
- ラテンアメリカの男性の性腺機能低下症の市場シェア：タイプ別 (2017-2028)
ラテンアメリカの男性の性腺機能低下症市場規模：アプリケーション別
- ラテンアメリカの男性の性腺機能低下症市場規模：アプリケーション別 (2017-2022)
- ラテンアメリカの男性の性腺機能低下症市場規模：アプリケーション別 (2023-2028)
- ラテンアメリカの男性の性腺機能低下症の市場シェア：アプリケーション別 (2017-2028)
ラテンアメリカの男性の性腺機能低下症市場規模：国別
- ラテンアメリカの男性の性腺機能低下症市場規模：国別 (2017-2022)
- ラテンアメリカの男性の性腺機能低下症市場規模：国別 (2023-2028)
- メキシコ
- ブラジル

第10章中東・アフリカ

中東・アフリカの男性の性腺機能低下症市場規模 (2017-2028)
中東・アフリカの男性の性腺機能低下症市場規模：タイプ別
- 中東・アフリカの男性の性腺機能低下症市場規模：タイプ別 (2017-2022)
- 中東・アフリカの男性の性腺機能低下症市場規模：タイプ別 (2023-2028)
- 中東・アフリカの男性の性腺機能低下症の市場シェア：タイプ別 (2017-2028)
中東・アフリカの男性の性腺機能低下症市場規模：アプリケーション別
- 中東・アフリカの男性の性腺機能低下症市場規模：アプリケーション別 (2017-2022)
- 中東・アフリカの男性の性腺機能低下症市場規模：アプリケーション別 (2023-2028)
- 中東・アフリカの男性の性腺機能低下症の市場シェア：アプリケーション別 (2017-2028)
中東・アフリカの男性の性腺機能低下症市場規模：国別
- 中東・アフリカの男性の性腺機能低下症市場規模：国別 (2017-2022)
- 中東・アフリカの男性の性腺機能低下症市場規模：国別 (2023-2028)
- トルコ
- サウジアラビア
- UAE

第11章主要企業のプロファイル

Astrazeneca Plc.
Merck & Co. Inc.
Laboratories Genevrier
Allergan Plc.
Endo International Plc.
Ferring
AbbVie Inc.
Eli Lilly and Company Ltd.
Finox Biotech
Teva Pharmaceutical Industries Ltd.
Bayer AG
IBSA Institut Biochimque

第12章アナリストによる分析/結論

第13章付録

図表

Table 1. Global Male Hypogonadism Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Testosterone Replacement Therapy
Table 3. Key Players of Gonadotropin-Releasing Hormones Therapy
Table 4. Global Male Hypogonadism Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Male Hypogonadism Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Male Hypogonadism Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Male Hypogonadism Market Share by Region (2017-2022)
Table 8. Global Male Hypogonadism Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Male Hypogonadism Market Share by Region (2023-2028)
Table 10. Male Hypogonadism Market Trends
Table 11. Male Hypogonadism Market Drivers
Table 12. Male Hypogonadism Market Challenges
Table 13. Male Hypogonadism Market Restraints
Table 14. Global Male Hypogonadism Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Male Hypogonadism Revenue Share by Players (2017-2022)
Table 16. Global Top Male Hypogonadism by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2021)
Table 17. Ranking of Global Top Male Hypogonadism Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Male Hypogonadism Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Male Hypogonadism Product Solution and Service
Table 21. Date of Enter into Male Hypogonadism Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Male Hypogonadism Revenue Market Share by Type (2017-2022)
Table 25. Global Male Hypogonadism Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Male Hypogonadism Revenue Market Share by Type (2023-2028)
Table 27. Global Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Male Hypogonadism Revenue Share by Application (2017-2022)
Table 29. Global Male Hypogonadism Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Male Hypogonadism Revenue Share by Application (2023-2028)
Table 31. North America Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Male Hypogonadism Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Male Hypogonadism Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
Table 61. Astrazeneca Plc. Company Details
Table 62. Astrazeneca Plc. Business Overview
Table 63. Astrazeneca Plc. Male Hypogonadism Product
Table 64. Astrazeneca Plc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 65. Astrazeneca Plc. Recent Developments
Table 66. Merck & Co. Inc. Company Details
Table 67. Merck & Co. Inc. Business Overview
Table 68. Merck & Co. Inc. Male Hypogonadism Product
Table 69. Merck & Co. Inc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 70. Merck & Co. Inc. Recent Developments
Table 71. Laboratories Genevrier Company Details
Table 72. Laboratories Genevrier Business Overview
Table 73. Laboratories Genevrier Male Hypogonadism Product
Table 74. Laboratories Genevrier Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 75. Laboratories Genevrier Recent Developments
Table 76. Allergan Plc. Company Details
Table 77. Allergan Plc. Business Overview
Table 78. Allergan Plc. Male Hypogonadism Product
Table 79. Allergan Plc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 80. Allergan Plc. Recent Developments
Table 81. Endo International Plc. Company Details
Table 82. Endo International Plc. Business Overview
Table 83. Endo International Plc. Male Hypogonadism Product
Table 84. Endo International Plc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 85. Endo International Plc. Recent Developments
Table 86. Ferring Company Details
Table 87. Ferring Business Overview
Table 88. Ferring Male Hypogonadism Product
Table 89. Ferring Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 90. Ferring Recent Developments
Table 91. AbbVie Inc. Company Details
Table 92. AbbVie Inc. Business Overview
Table 93. AbbVie Inc. Male Hypogonadism Product
Table 94. AbbVie Inc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 95. AbbVie Inc. Recent Developments
Table 96. Eli Lilly and Company Ltd. Company Details
Table 97. Eli Lilly and Company Ltd. Business Overview
Table 98. Eli Lilly and Company Ltd. Male Hypogonadism Product
Table 99. Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 100. Eli Lilly and Company Ltd. Recent Developments
Table 101. Finox Biotech Company Details
Table 102. Finox Biotech Business Overview
Table 103. Finox Biotech Male Hypogonadism Product
Table 104. Finox Biotech Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 105. Finox Biotech Recent Developments
Table 106. Teva Pharmaceutical Industries Ltd. Company Details
Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
Table 108. Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product
Table 109. Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 110. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 111. Bayer AG Company Details
Table 112. Bayer AG Business Overview
Table 113. Bayer AG Male Hypogonadism Product
Table 114. Bayer AG Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 115. Bayer AG Recent Developments
Table 116. IBSA Institut Biochimque Company Details
Table 117. IBSA Institut Biochimque Business Overview
Table 118. IBSA Institut Biochimque Male Hypogonadism Product
Table 119. IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
Table 120. IBSA Institut Biochimque Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Male Hypogonadism Market Share by Type: 2021 VS 2028
Figure 2. Testosterone Replacement Therapy Features
Figure 3. Gonadotropin-Releasing Hormones Therapy Features
Figure 4. Global Male Hypogonadism Market Share by Application: 2021 VS 2028
Figure 5. Kallmann Syndrome Case Studies
Figure 6. Klinefelters Syndrome Case Studies
Figure 7. Pituitary Disorders Case Studies
Figure 8. Others Case Studies
Figure 9. Male Hypogonadism Report Years Considered
Figure 10. Global Male Hypogonadism Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Male Hypogonadism Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Male Hypogonadism Market Share by Region: 2021 VS 2028
Figure 13. Global Male Hypogonadism Market Share by Players in 2021
Figure 14. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Male Hypogonadism Revenue in 2021
Figure 16. North America Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Male Hypogonadism Market Size Market Share by Type (2017-2028)
Figure 18. North America Male Hypogonadism Market Size Market Share by Application (2017-2028)
Figure 19. North America Male Hypogonadism Market Size Share by Country (2017-2028)
Figure 20. United States Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Male Hypogonadism Market Size Market Share by Type (2017-2028)
Figure 24. Europe Male Hypogonadism Market Size Market Share by Application (2017-2028)
Figure 25. Europe Male Hypogonadism Market Size Share by Country (2017-2028)
Figure 26. Germany Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Male Hypogonadism Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Male Hypogonadism Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Male Hypogonadism Market Size Share by Region (2017-2028)
Figure 36. China Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 42. Latin America Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Male Hypogonadism Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Male Hypogonadism Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Male Hypogonadism Market Size Share by Country (2017-2028)
Figure 46. Mexico Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Male Hypogonadism Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Male Hypogonadism Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Male Hypogonadism Market Size Share by Country (2017-2028)
Figure 52. Turkey Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Astrazeneca Plc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 56. Merck & Co. Inc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 57. Laboratories Genevrier Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 58. Allergan Plc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 59. Endo International Plc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 60. Ferring Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 61. AbbVie Inc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 62. Eli Lilly and Company Ltd. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 63. Finox Biotech Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 64. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 65. Bayer AG Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 66. IBSA Institut Biochimque Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

This research report focuses on the Male Hypogonadism Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Report Business Overview

1.1 Study Scope
1.2 Market Analysis by Type
- 1.2.1 Global Male Hypogonadism Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Testosterone Replacement Therapy
- 1.2.3 Gonadotropin-Releasing Hormones Therapy
1.3 Market by Application
- 1.3.1 Global Male Hypogonadism Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Kallmann Syndrome
- 1.3.3 Klinefelters Syndrome
- 1.3.4 Pituitary Disorders
- 1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends

2.1 Global Male Hypogonadism Market Perspective (2017-2028)
2.2 Male Hypogonadism Growth Trends by Region
- 2.2.1 Male Hypogonadism Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Male Hypogonadism Historic Market Size by Region (2017-2022)
- 2.2.3 Male Hypogonadism Forecasted Market Size by Region (2023-2028)
2.3 Male Hypogonadism Market Dynamics
- 2.3.1 Male Hypogonadism Industry Trends
- 2.3.2 Male Hypogonadism Market Drivers
- 2.3.3 Male Hypogonadism Market Challenges
- 2.3.4 Male Hypogonadism Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Male Hypogonadism Players by Revenue
- 3.1.1 Global Top Male Hypogonadism Players by Revenue (2017-2022)
- 3.1.2 Global Male Hypogonadism Revenue Market Share by Players (2017-2022)
3.2 Global Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Male Hypogonadism Revenue
3.4 Global Male Hypogonadism Market Concentration Ratio
- 3.4.1 Global Male Hypogonadism Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Revenue in 2021
3.5 Male Hypogonadism Key Players Head office and Area Served
3.6 Key Players Male Hypogonadism Product Solution and Service
3.7 Date of Enter into Male Hypogonadism Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Male Hypogonadism Breakdown Data by Type

4.1 Global Male Hypogonadism Historic Market Size by Type (2017-2022)
4.2 Global Male Hypogonadism Forecasted Market Size by Type (2023-2028)

5 Male Hypogonadism Breakdown Data by Application

5.1 Global Male Hypogonadism Historic Market Size by Application (2017-2022)
5.2 Global Male Hypogonadism Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Male Hypogonadism Market Size (2017-2028)
6.2 North America Male Hypogonadism Market Size by Type
- 6.2.1 North America Male Hypogonadism Market Size by Type (2017-2022)
- 6.2.2 North America Male Hypogonadism Market Size by Type (2023-2028)
- 6.2.3 North America Male Hypogonadism Market Share by Type (2017-2028)
6.3 North America Male Hypogonadism Market Size by Application
- 6.3.1 North America Male Hypogonadism Market Size by Application (2017-2022)
- 6.3.2 North America Male Hypogonadism Market Size by Application (2023-2028)
- 6.3.3 North America Male Hypogonadism Market Share by Application (2017-2028)
6.4 North America Male Hypogonadism Market Size by Country
- 6.4.1 North America Male Hypogonadism Market Size by Country (2017-2022)
- 6.4.2 North America Male Hypogonadism Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada

7 Europe

7.1 Europe Male Hypogonadism Market Size (2017-2028)
7.2 Europe Male Hypogonadism Market Size by Type
- 7.2.1 Europe Male Hypogonadism Market Size by Type (2017-2022)
- 7.2.2 Europe Male Hypogonadism Market Size by Type (2023-2028)
- 7.2.3 Europe Male Hypogonadism Market Share by Type (2017-2028)
7.3 Europe Male Hypogonadism Market Size by Application
- 7.3.1 Europe Male Hypogonadism Market Size by Application (2017-2022)
- 7.3.2 Europe Male Hypogonadism Market Size by Application (2023-2028)
- 7.3.3 Europe Male Hypogonadism Market Share by Application (2017-2028)
7.4 Europe Male Hypogonadism Market Size by Country
- 7.4.1 Europe Male Hypogonadism Market Size by Country (2017-2022)
- 7.4.2 Europe Male Hypogonadism Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Male Hypogonadism Market Size (2017-2028)
8.2 Asia-Pacific Male Hypogonadism Market Size by Type
- 8.2.1 Asia-Pacific Male Hypogonadism Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Male Hypogonadism Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Male Hypogonadism Market Share by Type (2017-2028)
8.3 Asia-Pacific Male Hypogonadism Market Size by Application
- 8.3.1 Asia-Pacific Male Hypogonadism Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Male Hypogonadism Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Male Hypogonadism Market Share by Application (2017-2028)
8.4 Asia-Pacific Male Hypogonadism Market Size by Region
- 8.4.1 Asia-Pacific Male Hypogonadism Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Male Hypogonadism Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia

9 Latin America

9.1 Latin America Male Hypogonadism Market Size (2017-2028)
9.2 Latin America Male Hypogonadism Market Size by Type
- 9.2.1 Latin America Male Hypogonadism Market Size by Type (2017-2022)
- 9.2.2 Latin America Male Hypogonadism Market Size by Type (2023-2028)
- 9.2.3 Latin America Male Hypogonadism Market Share by Type (2017-2028)
9.3 Latin America Male Hypogonadism Market Size by Application
- 9.3.1 Latin America Male Hypogonadism Market Size by Application (2017-2022)
- 9.3.2 Latin America Male Hypogonadism Market Size by Application (2023-2028)
- 9.3.3 Latin America Male Hypogonadism Market Share by Application (2017-2028)
9.4 Latin America Male Hypogonadism Market Size by Country
- 9.4.1 Latin America Male Hypogonadism Market Size by Country (2017-2022)
- 9.4.2 Latin America Male Hypogonadism Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Male Hypogonadism Market Size (2017-2028)
10.2 Middle East & Africa Male Hypogonadism Market Size by Type
- 10.2.1 Middle East & Africa Male Hypogonadism Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Male Hypogonadism Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Male Hypogonadism Market Share by Type (2017-2028)
10.3 Middle East & Africa Male Hypogonadism Market Size by Application
- 10.3.1 Middle East & Africa Male Hypogonadism Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Male Hypogonadism Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Male Hypogonadism Market Share by Application (2017-2028)
10.4 Middle East & Africa Male Hypogonadism Market Size by Country
- 10.4.1 Middle East & Africa Male Hypogonadism Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Male Hypogonadism Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE

11 Key Players Profiles

11.1 Astrazeneca Plc.
- 11.1.1 Astrazeneca Plc. Company Details
- 11.1.2 Astrazeneca Plc. Business Overview
- 11.1.3 Astrazeneca Plc. Male Hypogonadism Introduction
- 11.1.4 Astrazeneca Plc. Revenue in Male Hypogonadism Business (2017-2022)
- 11.1.5 Astrazeneca Plc. Recent Developments
11.2 Merck & Co. Inc.
- 11.2.1 Merck & Co. Inc. Company Details
- 11.2.2 Merck & Co. Inc. Business Overview
- 11.2.3 Merck & Co. Inc. Male Hypogonadism Introduction
- 11.2.4 Merck & Co. Inc. Revenue in Male Hypogonadism Business (2017-2022)
- 11.2.5 Merck & Co. Inc. Recent Developments
11.3 Laboratories Genevrier
- 11.3.1 Laboratories Genevrier Company Details
- 11.3.2 Laboratories Genevrier Business Overview
- 11.3.3 Laboratories Genevrier Male Hypogonadism Introduction
- 11.3.4 Laboratories Genevrier Revenue in Male Hypogonadism Business (2017-2022)
- 11.3.5 Laboratories Genevrier Recent Developments
11.4 Allergan Plc.
- 11.4.1 Allergan Plc. Company Details
- 11.4.2 Allergan Plc. Business Overview
- 11.4.3 Allergan Plc. Male Hypogonadism Introduction
- 11.4.4 Allergan Plc. Revenue in Male Hypogonadism Business (2017-2022)
- 11.4.5 Allergan Plc. Recent Developments
11.5 Endo International Plc.
- 11.5.1 Endo International Plc. Company Details
- 11.5.2 Endo International Plc. Business Overview
- 11.5.3 Endo International Plc. Male Hypogonadism Introduction
- 11.5.4 Endo International Plc. Revenue in Male Hypogonadism Business (2017-2022)
- 11.5.5 Endo International Plc. Recent Developments
11.6 Ferring
- 11.6.1 Ferring Company Details
- 11.6.2 Ferring Business Overview
- 11.6.3 Ferring Male Hypogonadism Introduction
- 11.6.4 Ferring Revenue in Male Hypogonadism Business (2017-2022)
- 11.6.5 Ferring Recent Developments
11.7 AbbVie Inc.
- 11.7.1 AbbVie Inc. Company Details
- 11.7.2 AbbVie Inc. Business Overview
- 11.7.3 AbbVie Inc. Male Hypogonadism Introduction
- 11.7.4 AbbVie Inc. Revenue in Male Hypogonadism Business (2017-2022)
- 11.7.5 AbbVie Inc. Recent Developments
11.8 Eli Lilly and Company Ltd.
- 11.8.1 Eli Lilly and Company Ltd. Company Details
- 11.8.2 Eli Lilly and Company Ltd. Business Overview
- 11.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Introduction
- 11.8.4 Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2017-2022)
- 11.8.5 Eli Lilly and Company Ltd. Recent Developments
11.9 Finox Biotech
- 11.9.1 Finox Biotech Company Details
- 11.9.2 Finox Biotech Business Overview
- 11.9.3 Finox Biotech Male Hypogonadism Introduction
- 11.9.4 Finox Biotech Revenue in Male Hypogonadism Business (2017-2022)
- 11.9.5 Finox Biotech Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
- 11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
- 11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 11.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Introduction
- 11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2017-2022)
- 11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.11 Bayer AG
- 11.11.1 Bayer AG Company Details
- 11.11.2 Bayer AG Business Overview
- 11.11.3 Bayer AG Male Hypogonadism Introduction
- 11.11.4 Bayer AG Revenue in Male Hypogonadism Business (2017-2022)
- 11.11.5 Bayer AG Recent Developments
11.12 IBSA Institut Biochimque
- 11.12.1 IBSA Institut Biochimque Company Details
- 11.12.2 IBSA Institut Biochimque Business Overview
- 11.12.3 IBSA Institut Biochimque Male Hypogonadism Introduction
- 11.12.4 IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2017-2022)
- 11.12.5 IBSA Institut Biochimque Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

世界の男性の性腺機能低下症市場：考察と予測 (2028年まで)

Global Male Hypogonadism Market Insights, Forecast to 2028

目次

第1章レポート概要

第2章世界の市場成長トレンド

第3章競合情勢：主要企業別

第4章男性の性腺機能低下症内訳データ：タイプ別

第5章男性の性腺機能低下症内訳データ：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋地域

第9章ラテンアメリカ

第10章中東・アフリカ

第11章主要企業のプロファイル

第12章アナリストによる分析/結論

第13章付録

List of Figures

List of Figures

TABLE OF CONTENTS

1 Report Business Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Male Hypogonadism Breakdown Data by Type

5 Male Hypogonadism Breakdown Data by Application

6 North America

7 Europe

8 Asia-Pacific

9 Latin America

10 Middle East & Africa

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

世界の男性の性腺機能低下症市場：考察と予測 (2028年まで)

Global Male Hypogonadism Market Insights, Forecast to 2028

目次

第1章 レポート概要

第2章 世界の市場成長トレンド

第3章 競合情勢：主要企業別

第4章 男性の性腺機能低下症 内訳データ：タイプ別

第5章 男性の性腺機能低下症 内訳データ：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋地域

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 主要企業のプロファイル

第12章 アナリストによる分析/結論

第13章 付録

List of Figures

List of Figures

TABLE OF CONTENTS

1 Report Business Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Male Hypogonadism Breakdown Data by Type

5 Male Hypogonadism Breakdown Data by Application

6 North America

7 Europe

8 Asia-Pacific

9 Latin America

10 Middle East & Africa

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

第1章レポート概要

第2章世界の市場成長トレンド

第3章競合情勢：主要企業別

第4章男性の性腺機能低下症内訳データ：タイプ別

第5章男性の性腺機能低下症内訳データ：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋地域

第9章ラテンアメリカ

第10章中東・アフリカ

第11章主要企業のプロファイル

第12章アナリストによる分析/結論

第13章付録